|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
29
|
|
pubmed:dateCreated |
2007-10-10
|
|
pubmed:abstractText |
Resection of colorectal liver metastases (CLM) in selected patients has evolved as the standard of care during the last 20 years. In the absence of prospective randomized clinical trials, a survival benefit has been deduced relative to historical controls based on actuarial data. There is now sufficient follow-up on a significant number of patients to address the curative intent of resecting CLM.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4575-80
|
|
pubmed:meshHeading |
pubmed-meshheading:17925551-Adult,
pubmed-meshheading:17925551-Aged,
pubmed-meshheading:17925551-Colorectal Neoplasms,
pubmed-meshheading:17925551-Disease-Free Survival,
pubmed-meshheading:17925551-Female,
pubmed-meshheading:17925551-Humans,
pubmed-meshheading:17925551-Liver Neoplasms,
pubmed-meshheading:17925551-Male,
pubmed-meshheading:17925551-Middle Aged,
pubmed-meshheading:17925551-Neoplasm Metastasis,
pubmed-meshheading:17925551-Prognosis,
pubmed-meshheading:17925551-Retrospective Studies,
pubmed-meshheading:17925551-Risk Factors,
pubmed-meshheading:17925551-Time Factors,
pubmed-meshheading:17925551-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Actual 10-year survival after resection of colorectal liver metastases defines cure.
|
|
pubmed:affiliation |
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. dangelim@mskcc.org
|
|
pubmed:publicationType |
Journal Article
|
